Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Neuropeptide Y ELISA Kit (AC3724)
Cat.#: ASET-2313
Specifications
Description Human Neuropeptide Y ELISA Kit allows for the in vitro quantitative determination of human Neuropeptide Y concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2522 Human Nogo ELISA Kit (AC3933) Quantitative inquiry ASET-2453 Human CLSTN1 ELISA Kit (AC3864) Quantitative inquiry ASET-2161 Mouse Niemann Pick C1 ELISA Kit (AC3572) Quantitative inquiry ASET-1011 Rat PTN ELISA Kit (AC2422) Quantitative inquiry ASET-1395 Rat Glucose 6 Phosphate Isomerase ELISA Kit (AC2806) Quantitative inquiry ASET-2506 Bovine Antidiuretic Hormone ELISA Kit (AC3917) Quantitative inquiry ASET-1860 Human NR1D1 ELISA Kit (AC3271) Quantitative inquiry ASET-1620 Human SOX2 ELISA Kit (AC3031) Quantitative inquiry ASET-1137 Rat SOX9 ELISA Kit (AC2548) Quantitative inquiry ASET-2274 Human ABCA1 ELISA Kit (AC3685) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket